| http://www.w3.org/ns/prov#value | - Therefore, known CYP3A inducers such as rifampicin, carbamazepine, and other inducers of cytochromes P450 are not anticipated to have significant effect on the pharmacokinetics of the active metabolite.Effects of Efient on other medicinal productsDigoxin: Prasugrel has no clinically significant effect on the pharmacokinetics of digoxin.Medicinal products metabolised by CYP2C9: Prasugrel did not in
|
